CDH11通过FGFR1促进严重喘中的呼吸道中性质炎症
Haixiong Tang1, Lin Fu2, Changyun Yang2
1Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
概括
卡德林-11 (CDH11) 在严重喘中促进中性友炎症. 阻断CDH11减少了喘模型中的炎症标志物和气道过敏反应,这表明了治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 卡德林-11 (CDH11) 是一种细胞-细胞粘附蛋白,参与组织修复和炎症.
- 严重喘的特点是复杂的炎症过程.
- 对于CDH11在严重喘病原体中的特定作用尚不清楚.
研究的目的:
- 研究CDH11在严重喘中的作用.
- 在喘模型中探索CDH11对抗的治疗潜力.
- 为了阐明CDH11介导的肺炎的潜在机制.
主要方法:
- 对来自严重喘患者和健康对照者的支气管活检样本的分析.
- 建立了两种严重喘的小鼠模型:多二酸 (TDI) 和卵胺/完全弗洛恩德辅助剂 (OVA/CFA).
- 使用SD133的CDH11的药理学对抗作用,再组合CDH11的使用,以及在体内抑制纤维细胞生长因子受体1 (FGFR1).
主要成果:
- 在严重喘患者的呼吸道粘膜中,CDH11表达被上调.
- 在OVA/CFA模型中,CDH11对抗性降低了中性粒细胞积累和IL-6的产生,但并没有降低氨酸性炎症或气道过敏反应.
- 在TDI模型中,CDH11对抗性降低了气道过敏反应,中性友性炎症,IL-6和TNF-α,而不会影响乙素或2型细胞因子.
- 再组合的CDH11诱导了中性粒细胞的招募,由FGFR1抑制减弱.
结论:
- CDH11有助于呼吸道中性友好性炎症和严重喘中的高反应性.
- CDH11对抗性显示出治疗严重喘中的特定炎症途径的潜力.
- FGFR1信号通路介导CDH11诱导的肺中的中性恋炎症.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K


